Shorted
Bubs Australia logo
BUB
Food, Beverage & Tobacco

Bubs Australia

Short interest
0.00%
0.00 pp 30d
as of 5 Oct 2026
Reported shorts
29.2K
Shares on issue
894.130M

Bubs Australia (BUB) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Neutral
1d ago

Bubs Australia Allocates 13.05 Million 2026 Performance Rights to Key Staff and Management on October 13, 2026

Bubs Australia Limited (ASX:BUB) announced the issuance of 13,050,000 unquoted 2026 Performance Rights to key management personnel and other employees as part of its employee share ownership plan, with the securities granted on 13 October 2026. Key Highlights On 13 October 2026, Bubs Australia issued 13,050,000 unquoted 2026 Performance Rights (ASX code: BUBAM) under its employee incentive program. Key management personnel Richard Paine and Chris Rowe each received 1,500,000 of these performa...

Continue reading
Kalkine
Positive
28 Sept

Can Bubs (ASX:BUB) Turn FDA Approval Into Lasting US Growth?

Highlights Bubs has secured permanent approval from the US regulator to keep supplying infant formula to American retailers. The shares surged when trading resumed but have since given back much of that jump. The United States now drives most of the group's revenue, making execution there central to the outlook. Bubs Australia (ASX:BUB) is working to turn its newly secured permanent US Food and Drug Administration approval for infant formula into sustained sales growth, after the regulatory w...

Continue reading
Kalkine
Neutral
25 Sept

What Could Shape Bubs Australia Ltd (ASX:BUB) as Consumer Preferences Evolve?

Highlights Today's market backdrop puts a premium on company-specific evidence and financial flexibility. Bubs Australia Ltd is viewed through consumer shares, where household demand, pricing, brand relevance and the ability to protect margins through changing spending conditions matter. The focus stays on observable operating signals rather than unsupported forecasting. Australian shares face a cautious session as global rates and energy markets reshape the tone. Bubs Australia Ltd (ASX:BUB)...

Continue reading
Kalkine
Neutral
14 Sept

Bubs Australia Announces 2026 AGM Date and Director Nomination Deadline

Bubs Australia (ASX:BUB), a prominent infant nutrition company specializing in organic and specialty infant formulas such as goat milk and grass-fed varieties, has announced its 2026 Annual General Meeting will take place on Wednesday, 18 November 2026. The deadline for submitting director nominations is set for Tuesday, 6 October 2026. Key Points Bubs Australia's 2026 Annual General Meeting is scheduled for Wednesday, 18 November 2026. The deadline for director nominations is Tuesday, 6 Octo...

Continue reading
Kalkine
Neutral
9 Sept

Is Bubs Australia (ASX:BUB) Showing a New Chart Pattern?

Highlights Bubs Australia has placed trading pattern at the centre of current exchange interest through its current notice. The update directs attention toward price behaviour, volume context and disclosure timing without removing the need for careful evidence review. Exchange assessment depends on delivery quality, clear reporting and alignment between strategy, funding and operating conditions. Bubs Australia (ASX:BUB) has drawn attention during the latest completed Australian market sessio...

Continue reading
Kalkine
Positive
29 May

Bubs Faces Fresh Market Test Amid Growth Challenges

Highlights Revenue outlook draws market attention. US expansion remains a key focus. Supply chain pressures continue to influence performance. Bubs Australia Ltd (BUB) has released an updated outlook highlighting ongoing operational and market challenges. While demand remains healthy across key regions, factors such as logistics costs, regulatory changes, and competitive conditions continue to shape the company's near-term business environment. The infant nutrition sector remains one of...

Continue reading